BioNTech SE - ADR
22UAy.DE
LATEST TRADE
303.00EUR
CHANGE
14.80(+5.14%)
VOLUME
98,261
TODAY'S RANGE
298.10 - 303.70
52 WEEK RANGE
65.50 - 303.70
As of 3:42 AM PDT Aug 04 on the NASDAQ ∙ Minimum 15 minute delay
Previous Close288.20
Open302.80
Volume64,027
3M AVG Volume68.29
Today's High303.30
Today's Low298.10
52 Week High303.30
52 Week Low65.50
Shares Out (MIL)241.52
Market Cap (MIL)82,167.88
Forward P/E9.20
Dividend (Yield %)--
Chart not available
Token expired
Loading new token...
OK
Advanced Charting
Next Event
Q2 2021 BioNTech SE Earnings CallAug 09, 2021
Latest Developments
More
15 days ago
Pfizer And BioNTech Sign LOI With Biovac Institute
a month ago
EMA Says CHMP Approves 2 Additional Manufacturing Sites For Biontech/Pfizer's COVID-19 Vaccine
2 months ago
Biontech Says First Patient With Advanced Melanoma Dosed In Phase 2 Clinical Trial Of MRNA-Based BNT111
About BioNTech SE - ADR
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
INDUSTRY
Biotechnology & Drugs
CONTACT INFO
An der Goldgrube 12
55131
Germany
+49.6131.90840
https://biontech.de/
Key Stats
2.62 mean rating - 13 analysts
SELLHOLDBUY
REVENUE (MM, EUR)
2019
0.1K
2020
0.5K
2021(E)
12.5K
EPS (EUR)
2019
-0.850
2020
0.060
2021(E)
29.606
Price To Earnings (TTM)63.05
Price To Sales (TTM)27.66
Price To Book (MRQ)27.48
Price To Cash Flow (TTM)55.85
Total Debt To Equity (MRQ)23.21
LT Debt To Equity (MRQ)9.43
Return On Investment (TTM)68.70
Return On Equity (TTM)48.48
Latest News
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.
Apps​Newsletters​Advertise with UsAdvertising Guidelines​Cookies​Terms of UsePrivacyDo Not Sell My Personal Information
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2021 Reuters. All Rights Reserved.
Olympics-Another record on track, Belarus sprinter heads for Poland and the fastest woman in the world can’t outrun TV rights